This product is part of the RAND Institute for Civil Justice working paper series. RAND working papers are intended to share researchers’ latest findings and to solicit additional peer review. This paper has been peer reviewed but not edited. Unless otherwise indicated, working papers can be quoted and cited without permission of the author, provided the source is clearly referred to as a working paper. RAND’s publications do not necessarily reflect the opinions of its research clients and sponsors.
is a registered trademark.
Understanding Mass Tort Defendant Incentives for Confidential Settlements
Lessons from Bayer’s Cerivastatin Litigation Strategy
JAMES M. ANDERSON